We are live on ! Find out more
Fayez Sarofim & Co

Fayez Sarofim & Co Portfolio holdings

AUM $39.1B
1-Year Est. Return 15.14%
This Fund
S&P 500
This Quarter Est. Return
+2.54%
1 Year Est. Return
+15.14%
3 Year Est. Return
+57.14%
5 Year Est. Return
+86.44%
10 Year Est. Return
+860.5%
AUM
$41.7B
AUM Growth
-$1.46B
Cap. Flow
-$1.81B
Cap. Flow %
-4.34%
Top 10 Hldgs %
47.71%
Holding
311
New
6
Increased
45
Reduced
135
Closed
14

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$144M
2
TSM icon
TSMC
TSM
+$128M
3
ABBV icon
AbbVie
ABBV
+$95.9M
4
INTU icon
Intuit
INTU
+$90.3M
5
META icon
Meta Platforms (Facebook)
META
+$88.1M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$259M
2
PG icon
Procter & Gamble
PG
+$217M
3
NVO
Novo Nordisk
NVO
+$159M
4
UNP icon
Union Pacific
UNP
+$146M
5
ADBE icon
Adobe
ADBE
+$138M

Sector Composition

Rank Sector Weight
1 Technology 31.76%
2 Financials 18.71%
3 Consumer Staples 9.74%
4 Communication Services 9.51%
5 Healthcare 9.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HHH icon
276
Howard Hughes
HHH
$3.92B
$234K ﹤0.01%
2,931
MELI icon
277
Mercado Libre
MELI
$97.5B
$232K ﹤0.01%
115
WRB icon
278
W.R. Berkley
WRB
$26.8B
$231K ﹤0.01%
3,300
-349
-10% -$25.7K
IEFA icon
279
iShares Core MSCI EAFE ETF
IEFA
$194B
$229K ﹤0.01%
2,560
QUAL icon
280
iShares MSCI USA Quality Factor ETF
QUAL
$47.7B
$228K ﹤0.01%
1,149
ENB icon
281
Enbridge
ENB
$113B
$226K ﹤0.01%
4,726
JCI icon
282
Johnson Controls International
JCI
$93.1B
$225K ﹤0.01%
1,877
OXY icon
283
Occidental Petroleum
OXY
$53.5B
$224K ﹤0.01%
5,451
CXT icon
284
Crane NXT
CXT
$3.01B
$221K ﹤0.01%
4,699
WLKP icon
285
Westlake Chemical Partners
WLKP
$750M
$219K ﹤0.01%
11,500
SO icon
286
Southern Company
SO
$107B
$218K ﹤0.01%
2,500
TCBI icon
287
Texas Capital Bancshares
TCBI
$4.35B
$217K ﹤0.01%
2,400
MSGS icon
288
Madison Square Garden
MSGS
$9.42B
$213K ﹤0.01%
+824
New +$188K
TER icon
289
Teradyne
TER
$60.9B
$213K ﹤0.01%
+1,100
New +$189K
PPG icon
290
PPG Industries
PPG
$26.5B
$205K ﹤0.01%
2,000
ARLP icon
291
Alliance Resource Partners
ARLP
$3.27B
$204K ﹤0.01%
8,800
PWR icon
292
Quanta Services
PWR
$103B
$203K ﹤0.01%
+482
New +$212K
BIL icon
293
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$46.9B
$201K ﹤0.01%
2,200
-435
-17% -$39.8K
ORN icon
294
Orion Group Holdings
ORN
$418M
$196K ﹤0.01%
19,674
GLDD
295
DELISTED
Great Lakes Dredge & Dock
GLDD
$170K ﹤0.01%
12,966
-4,546
-26% -$56K
OGN icon
296
Organon & Co
OGN
$3.56B
$123K ﹤0.01%
17,197
-2,500
-13% -$19.8K
NAUT icon
297
Nautilus Biotechnolgy
NAUT
$118M
$87.8K ﹤0.01%
45,000
AJG icon
298
Arthur J. Gallagher & Co
AJG
$64.3B
-659
Closed -$204K
BRCC icon
299
BRC Inc
BRCC
$253M
-1,574,529
Closed -$2.46M
CQP icon
300
Cheniere Energy
CQP
$31B
-6,829
Closed -$368K

Similar funds

Fayez Sarofim & Co's Q4 2025 Portfolio in Review

As of Q4 2025, Fayez Sarofim & Co held 311 positions worth $41.7B, down 3.4% from $43.1B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Fayez Sarofim & Co withdrew a net $1.81B in Q4 2025, closing 14 positions and reducing 135 holdings. Its most notable exit was TotalEnergies, an estimated $8.72M position sold in full.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 32% a quarter earlier, followed by Financials and Consumer Staples.

Against the trend, Fayez Sarofim & Co opened a new position in Banco Bilbao Vizcaya Argentaria worth $395K.

  • Fayez Sarofim & Co's largest Q4 2025 buy was Banco Bilbao Vizcaya Argentaria: 16,935 shares worth $395K.
  • Fayez Sarofim & Co added most to NVIDIA in Q4 2025, an estimated $144M increase.
  • Fayez Sarofim & Co's biggest Q4 2025 reduction was Apple, cutting an estimated $259M.
  • Fayez Sarofim & Co fully exited TotalEnergies in Q4 2025, selling an estimated $8.72M.
  • Fayez Sarofim & Co's ten largest holdings make up 48% of its $41.7B portfolio in Q4 2025.
  • Fayez Sarofim & Co opened 6 new positions and closed 14 in Q4 2025.
  • Fayez Sarofim & Co's portfolio value fell 3.4% quarter-over-quarter to $41.7B.

Based on Fayez Sarofim & Co's 13F filing for Q4 2025, filed 13 Feb 2026.